CN106075136A - One treats hyperthyroid Chinese medicine composition and preparation method thereof - Google Patents

One treats hyperthyroid Chinese medicine composition and preparation method thereof Download PDF

Info

Publication number
CN106075136A
CN106075136A CN201610582700.5A CN201610582700A CN106075136A CN 106075136 A CN106075136 A CN 106075136A CN 201610582700 A CN201610582700 A CN 201610582700A CN 106075136 A CN106075136 A CN 106075136A
Authority
CN
China
Prior art keywords
grams
gram
chinese medicine
medicine composition
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610582700.5A
Other languages
Chinese (zh)
Inventor
华菊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201610582700.5A priority Critical patent/CN106075136A/en
Publication of CN106075136A publication Critical patent/CN106075136A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/618Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02Algae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • A61K36/076Poria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/62Nymphaeaceae (Water-lily family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/752Citrus, e.g. lime, orange or lemon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/83Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
    • A61K36/835Aquilaria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/888Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A61K36/8888Pinellia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8966Fritillaria, e.g. checker lily or mission bells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to one and treat hyperthyroid Chinese medicine composition and preparation method thereof, be prepared by the raw materials in: Concha Margaritifera 28 32 grams, Concretio silicea Bambusae seu schizostachyi 18 22 grams, Lignum Aquilariae Resinatum 13 17 grams, Plumula Nelumbinis 13 17 grams, Fructus Aurantii 8 12 grams, Sargassum 8 12 grams, Rhizoma Pinelliae Preparatum 8 12 grams, 8 12 grams of Poria, Bulbus Fritillariae Thunbergii 8 12 grams, Pericarpium Citri Reticulatae 57 grams, Cornu Saigae Tataricae 24 grams.The present invention has treatment, and hyperthyroidism is effective, preparation method simple, the advantage of low cost;According to clinical verification, the present invention is 89.1% for treating hyperthyroid effective percentage.

Description

One treats hyperthyroid Chinese medicine composition and preparation method thereof
Technical field
The present invention relates to technical field of Chinese medicines, particularly relate to one treat hyperthyroid Chinese medicine composition and Its preparation method.
Background technology
Hyperthyroidism is called for short hyperthyroidism, is owing to thyroid synthesis discharges too much thyroxin, causes body Hypermetabolism and sympathetic activation, cause cardiopalmus, perspire, take food and the most secondary disease increasing and losing weight.
Hyperthyroid patient is the most properly treated, and can cause and become thin and hyperthyroid heart disease.Patient becomes thin and usually holds It is susceptible to suffer from acute infectious disease infection to disable or dead.Hyperthyroid heart disease causes cardiac dilatation, arrhythmia, atrial fibrillation and mental and physical efforts Exhaustion, patient disability, even dead.
The hyperthyroid Chinese medicine composition of existing treatment exists that therapeutic effect is the best, preparation method is complicated, becomes The shortcomings such as this is higher.
Summary of the invention
The technical problem to be solved in the present invention is: for solving the deficiencies in the prior art, the invention provides one and treats first Shape gland Chinese medicine composition hyperactivity and preparation method thereof, the present invention have treatment hyperthyroidism effective, preparation Method is simple, the advantage of low cost.
One treats hyperthyroid Chinese medicine composition, is prepared by the raw materials in: Concha Margaritifera 28-32 Gram, Concretio silicea Bambusae seu schizostachyi 18-22 gram, Lignum Aquilariae Resinatum 13-17 gram, Plumula Nelumbinis 13-17 gram, Fructus Aurantii 8-12 gram, Sargassum 8-12 gram, Rhizoma Pinelliae Preparatum 8-12 Gram, 8-12 gram of Poria, Bulbus Fritillariae Thunbergii 8-12 gram, Pericarpium Citri Reticulatae 5-7 gram, Cornu Saigae Tataricae 2-4 gram.
The hyperthyroid Chinese medicine composition of described treatment, it is preferably prepared by the raw materials in: Concha Margaritifera 30 grams, Concretio silicea Bambusae seu schizostachyi 20 grams, Lignum Aquilariae Resinatum 15 grams, Plumula Nelumbinis 15 grams, Fructus Aurantii 10 grams, Sargassum 10 grams, Rhizoma Pinelliae Preparatum 10 grams, Poria 10 Gram, Bulbus Fritillariae Thunbergii 10 grams, Pericarpium Citri Reticulatae 6 grams, Cornu Saigae Tataricae 3 grams.
The described preparation method treating hyperthyroid Chinese medicine composition is: by described Chinese medicine composition by often Rule method is made concentrated pill or concentrates capsule.
Usage and consumption: taking the concentrated pill of the present invention every time or concentrate capsule 2-3 gram and be administered orally, every day is early, middle and late respectively takes Once;It within 30 days, it is a course for the treatment of.
The present invention is based on theory of Chinese medical science, chooses above-mentioned each raw material of Chinese medicine, has hard masses softening and resolving, dispersing the stagnated live-QI to relieve the stagnation of QI etc. Effect, thus reach to treat hyperthyroid purpose.
The had the beneficial effect that present invention of the present invention has treatment hyperthyroidism effect The best, preparation method is simple, the advantage of low cost;According to clinical verification, the present invention is hyperthyroid effectively for treatment Rate is 89.1%.
Detailed description of the invention
Embodiment 1:
One treats hyperthyroid Chinese medicine composition, is prepared by the raw materials in: Concha Margaritifera 30 grams, nandina Yellow 20 grams, Lignum Aquilariae Resinatum 15 grams, Plumula Nelumbinis 15 grams, Fructus Aurantii 10 grams, Sargassum 10 grams, Rhizoma Pinelliae Preparatum 10 grams, 10 grams of Poria, Bulbus Fritillariae Thunbergii 10 grams, Pericarpium Citri Reticulatae 6 grams, Cornu Saigae Tataricae 3 grams.
The described preparation method treating hyperthyroid Chinese medicine composition is: by described Chinese medicine composition by often Rule method is made concentrated pill or concentrates capsule.
Embodiment 2:
One treats hyperthyroid Chinese medicine composition, is prepared by the raw materials in: Concha Margaritifera 28 grams, nandina Huang 18 grams, Lignum Aquilariae Resinatum 13 grams, Plumula Nelumbinis 13 grams, Fructus Aurantii 8 grams, Sargassum 8 grams, Rhizoma Pinelliae Preparatum 8 grams, 8 grams of Poria, Bulbus Fritillariae Thunbergii 8 grams, Pericarpium Citri Reticulatae 5 Gram, Cornu Saigae Tataricae 2 grams.
The described preparation method treating hyperthyroid Chinese medicine composition is: by described Chinese medicine composition by often Rule method is made concentrated pill or concentrates capsule.
Embodiment 3:
One treats hyperthyroid Chinese medicine composition, is prepared by the raw materials in: Concha Margaritifera 32 grams, nandina Yellow 22 grams, Lignum Aquilariae Resinatum 17 grams, Plumula Nelumbinis 17 grams, Fructus Aurantii 12 grams, Sargassum 12 grams, Rhizoma Pinelliae Preparatum 12 grams, 12 grams of Poria, Bulbus Fritillariae Thunbergii 12 grams, Pericarpium Citri Reticulatae 7 grams, Cornu Saigae Tataricae 4 grams.
The described preparation method treating hyperthyroid Chinese medicine composition is: by described Chinese medicine composition by often Rule method is made concentrated pill or concentrates capsule.
Experimental example:
Use the present invention to treat 46 example patients suffered from hyperthyroidisms altogether, the maleest 19 examples, female 27 example, the age be 20-55 year;Suffer from Person takes the concentrated pill of the present invention every time or concentrates capsule 2-3 gram and be administered orally, and every day is early, middle and late respectively takes once, within 30 days, is a treatment Journey;
The standard of curative effect evaluation is:
Curing: transference cure, body weight increases, and pulse frequency is normal, and vascular murmur disappears, and every lab testing project recovers normal.
Take a turn for the better: symptom takes a turn for the better, and pulse frequency slows down, and vascular murmur alleviates, and lab testing project is normal.
Do not heal: symptom, sign, lab testing are all not improved.
Therapeutic outcome: the present invention treats patients suffered from hyperthyroidism 46 example, through the treatment of 2-4 the course for the treatment of, has 28 examples Obtaining healing, account for 60.9%, take a turn for the better 13 examples, accounts for 28.2%, and the most 5 examples account for 10.9%, and effective percentage is 89.1%.

Claims (3)

1. treat a hyperthyroid Chinese medicine composition, it is characterized in that, be prepared by the raw materials in: Margarita Mother 28-32 gram, Concretio silicea Bambusae seu schizostachyi 18-22 gram, Lignum Aquilariae Resinatum 13-17 gram, Plumula Nelumbinis 13-17 gram, Fructus Aurantii 8-12 gram, Sargassum 8-12 gram, method half Summer 8-12 gram, 8-12 gram of Poria, Bulbus Fritillariae Thunbergii 8-12 gram, Pericarpium Citri Reticulatae 5-7 gram, Cornu Saigae Tataricae 2-4 gram.
The hyperthyroid Chinese medicine composition for the treatment of the most according to claim 1, is characterized in that, by following weight portion Raw material make: Concha Margaritifera 30 grams, Concretio silicea Bambusae seu schizostachyi 20 grams, Lignum Aquilariae Resinatum 15 grams, Plumula Nelumbinis 15 grams, Fructus Aurantii 10 grams, Sargassum 10 grams, Rhizoma Pinelliae Preparatum 10 grams, 10 grams of Poria, Bulbus Fritillariae Thunbergii 10 grams, Pericarpium Citri Reticulatae 6 grams, Cornu Saigae Tataricae 3 grams.
The preparation method of the hyperthyroid Chinese medicine composition for the treatment of the most according to claim 1 and 2, its feature It is to be made concentrated pill according to a conventional method by described Chinese medicine composition or concentrate capsule.
CN201610582700.5A 2016-07-23 2016-07-23 One treats hyperthyroid Chinese medicine composition and preparation method thereof Pending CN106075136A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610582700.5A CN106075136A (en) 2016-07-23 2016-07-23 One treats hyperthyroid Chinese medicine composition and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610582700.5A CN106075136A (en) 2016-07-23 2016-07-23 One treats hyperthyroid Chinese medicine composition and preparation method thereof

Publications (1)

Publication Number Publication Date
CN106075136A true CN106075136A (en) 2016-11-09

Family

ID=57449684

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610582700.5A Pending CN106075136A (en) 2016-07-23 2016-07-23 One treats hyperthyroid Chinese medicine composition and preparation method thereof

Country Status (1)

Country Link
CN (1) CN106075136A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101156931A (en) * 2006-10-08 2008-04-09 天津市正道中医咨询服务中心 A Chinese medicine composition for vanishing sputum and dispelling knot
CN103041212A (en) * 2013-01-09 2013-04-17 上海浦东高星生物技术研究所 Hyperthyroidism inhibition pill

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101156931A (en) * 2006-10-08 2008-04-09 天津市正道中医咨询服务中心 A Chinese medicine composition for vanishing sputum and dispelling knot
CN103041212A (en) * 2013-01-09 2013-04-17 上海浦东高星生物技术研究所 Hyperthyroidism inhibition pill

Similar Documents

Publication Publication Date Title
WO2014079396A1 (en) Oil mixture for treating acne
CN104306897A (en) Traditional Chinese medicine composition for treating climacterium syndrome
CN102406778B (en) Traditional Chinese medicine composition for treating Alzheimer type dementia and preparation method thereof
CN106075136A (en) One treats hyperthyroid Chinese medicine composition and preparation method thereof
CN104383453B (en) Treat the Chinese medicine of craniocerebral injury manic disorder
CN104225061B (en) A kind of Chinese medicine treating type of deficiency of both QI and YIN viral myocarditis
CN104013851B (en) A kind of Chinese medicine preparation treating tinea pedis
CN103798472B (en) A kind of health protection tea and health care's preparation
CN104107242B (en) A kind of Chinese medicine composition for the treatment of hyperthyroidism and its production and use
CN106728747A (en) A kind of Traditional chinese medicine medicament formula for treating onychomycosis
CN105853833A (en) Traditional Chinese medicine wine for treating tinnitus and preparation method thereof
CN106166287A (en) A kind of Chinese medicine for treating skin pruritus
CN105832885A (en) Traditional Chinese medicine composition for treating insomnia
CN105055864A (en) Traditional Chinese medicine preparation for treating aplastic anemia
CN104784454A (en) Traditional Chinese medicine for treating hyperthyroidism
CN104666703A (en) Traditional Chinese medicine composition for treating obesity and preparation method of traditional Chinese medicine composition
CN105079340A (en) Traditional Chinese medicine for treating coronary heart disease with syndromes of qi deficiency and blood stasis
CN104013943A (en) Traditional Chinese medicine (TCM) preparation for treating beriberi
CN103520414B (en) Chinese medicament for treating bronchial asthma
CN103494941A (en) Traditional Chinese medicine composite for treating pharyngitis and preparation method thereof and application thereof
CN101293004B (en) Medicament for treating chyluria
CN109700868A (en) A kind of instant particles as Chinese medicine and preparation method thereof for treating psoriasis
CN108578552A (en) One kind controlling hypochondriacal diet therapy formula
CN108143914A (en) A kind of prescription for treating coronary heart disease
CN105748850A (en) Traditional Chinese medicine wine for treating coronary heart disease and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20161109